Blood cancers

PBS eases access to bortezomib for MM patients during COVID-19 pandemic

The PBS has temporarily suspended its limit on the maximum cycles of treatment (4) with bortezomib (Velcade) for newly diagnosed patients with multiple myeloma who are eligible for high dose chemotherapy and autologous stem cell transplant. The move to ease restriction on bortezomib induction treatment is to ensure that patients whose transplant might be delayed during ...

Already a member?

Login to keep reading.

© 2021 the limbic